CNMD Form 4: Todd Garner Disposes of 598 Shares at $52.45

Q: What did CNMD insider Todd W. Garner report on Form 4?

The Form 4 reports that Todd W. Garner sold 598 shares of CONMED common stock on 08/07/2025 at a price of $52.45 per share and beneficially owns 0 shares after the transaction.

Q: When was the Form 4 for CNMD filed and signed?

The transaction date is 08/07/2025 and the Form 4 was signed by power of attorney on 08/08/2025 .

Q: What position does the reporting person hold at CONMED (CNMD)?

The reporting person, Todd W. Garner, is listed as Executive Vice President & CFO of CONMED Corp.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Todd W. Garner, Executive Vice President & CFO of CONMED Corp (CNMD), reported a single insider sale. On 08/07/2025 he sold 598 shares of CONMED common stock at $52.45 per share, and the Form 4 reports he beneficially owns 0 shares following the transaction. The Form 4 was signed via power of attorney on 08/08/2025.

Positive

Transaction disclosed via Form 4, satisfying Section 16 reporting requirements
Form signed (via power of attorney) one day after the transaction, indicating prompt filing

Negative

Insider sold 598 shares, and the filing reports 0 shares beneficially owned following the sale
No explanation provided in the filing for the reason behind the sale

Insights

TL;DR: CFO sold 598 shares at $52.45, leaving no reported beneficial holdings; transaction disclosed on filed Form 4.

The filing documents a straightforward open-market sale by the company's CFO: 598 shares were disposed of at $52.45 on 08/07/2025. The report shows the reporting person holds 0 shares after the sale, indicating no remaining beneficial ownership recorded on this form. For investors, this is a transparency action required under Section 16; the filing does not provide rationale for the sale nor indicate any derivative transactions.

TL;DR: Disclosure appears routine and signed by power of attorney; no additional governance events are reported.

The Form 4 was executed via power of attorney on 08/08/2025, which is a common administrative practice. The disclosure meets Section 16 reporting of an insider sale. There are no indications of amendments, related derivative activity, or retained indirect ownership in this filing. From a governance perspective, the form shows compliance with reporting obligations but does not provide context about insider intent or company policy impacts.

Insider Trade Summary

Net Seller: 598 shares ($31,365)

Net Sell 1 txn

Insider Garner Todd W

Role Executive Vice President & CFO

Sold 598 shs ($31K)

Type	Security	Shares	Price	Value
Sale	Common Stock	598	$52.45	$31K

Holdings After Transaction: Common Stock — 0 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

08/08/2025 - 03:05 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Garner Todd W

(Last)

(First)

(Middle)

C/O CONMED CORPORATION

11311 CONCEPT BOULEVARD

(Street)

LARGO

33773

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
CONMED Corp [ CNMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Executive Vice President & CFO

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/07/2025		S		598	D	$52.45	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

	/s/ Thomas Fistek for Todd W. Garner by Power of Attorney	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did CNMD insider Todd W. Garner report on Form 4?

The Form 4 reports that Todd W. Garner sold 598 shares of CONMED common stock on 08/07/2025 at a price of $52.45 per share and beneficially owns 0 shares after the transaction.

When was the Form 4 for CNMD filed and signed?

The transaction date is 08/07/2025 and the Form 4 was signed by power of attorney on 08/08/2025.

Does the Form 4 indicate any derivative transactions or retained indirect ownership?

No. Table II (derivative securities) contains no reported entries, and Table I shows 0 shares beneficially owned following the sale.

What position does the reporting person hold at CONMED (CNMD)?

The reporting person, Todd W. Garner, is listed as Executive Vice President & CFO of CONMED Corp.

Was this Form 4 an amendment?

No amendment date is provided; the form lists the transaction date and the signature date but does not indicate it is an amendment.